Clinical Trials
Closed
Phase
Accrual
34%
Published
SWOG Clinical Trial Number
SWOG-9460
Phase IIb Randomized Chemoprevention Trial of N-(4-Hydroxyphenyl) Retinamide (4-HPR) in Transitional Cell Bladder Carcinoma
Activated
06-01-1996
Closed
10-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9619
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-9451
Induction Chemotherapy Followed by Chemoradiation for Organ Preservation in Patients with Advanced Resectable Cancer of the Hypopharynx and Base of Tongue, Phase II
Research Committee(s)
Head and Neck Cancer
Activated
04-12-1996
Closed
12-01-2001
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
SWOG-9518
Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas
Research Committee(s)
Sarcoma
Activated
04-01-1996
Closed
10-15-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9509
A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Vinorelbine and Cisplatin in Untreated Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-01-1996
Closed
01-01-1998
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9521
Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary
Research Committee(s)
Gynecologic Cancer
Activated
03-01-1996
Closed
11-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9407
Evaluation of Oral Estramustine and Oral Etoposide in Patients with Hormone Refractory Adenocarcinoma of the Prostate, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
03-01-1996
Closed
07-01-1996
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
SWOG-9505
Evaluation of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II
Research Committee(s)
Melanoma
Activated
01-01-1996
Closed
08-15-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9520
Controlled Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
Activated
12-15-1995
Closed
10-01-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9500
A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia
Research Committee(s)
Leukemia
Activated
12-15-1995
Closed
04-01-1997
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
SWOG-9458
Evaluation of Ki-67, p53 and Angiogenesis in Patients Registered to SWOG-8710, Ancillary
Research Committee(s)
Genitourinary Cancer
Activated
11-15-1995
Closed
11-01-1998
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
SWOG-9400
Treatment of Adult Lymphoblastic Leukemia: A Phase II Trial of An Induction Regimen Including PEG-L-Asparaginase in Previously Untreated Patients, Followed By Allogeneic Bone Marrow Transplantation or Further Chemotherapy In First Complete Remission
Research Committee(s)
Leukemia
Activated
07-15-1995
Closed
05-01-2000
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9438
Total Body Irradiation, Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy With Interleukin-2 Versus Observation for Patients With Non-Hodgkin's Lymphoma, A BMT Study, Phase III
Research Committee(s)
Lymphoma
Activated
05-15-1995
Closed
07-01-2004
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
SWOG-9346
Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
05-15-1995
Closed
09-01-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9413
Phase II Treatment with Etoposide (E), Leucovorin (L), 5-Fluorouracil (F) and Interferon Alpha 2b (I), (ELFI) + G-CSF for Locally Advanced or Recurrent Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-1995
Closed
03-15-1996
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
SWOG-9436 (NABTC-9403) (NCI T94-0184)
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma
Research Committee(s)
Brain Cancer
Activated
04-18-1995
Closed
02-04-1998
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
SWOG-9239
Phase II Trial of Sequential Modification of Immunosuppression, Interferon Alpha, and ProMACE-CytaBOM for Treatment of Post-Organ Transplant Lymphoproliferation
Research Committee(s)
Lymphoma
Activated
04-15-1995
Closed
08-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9420
A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1995
Closed
05-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9416
Induction Chemoradiotherapy Followed by Surgical Resection, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial
Research Committee(s)
Lung Cancer
Activated
04-15-1995
Closed
08-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9501
A Phase II Trial of Fludarabine and Mitoxantrone (FN) for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-01-1995
Closed
02-15-1996